相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Rapamycin antagonizes TNF induction of VCAM-1 on endothelial cells by inhibiting mTORC2
Chen Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands
Adam J. Pawson et al.
NUCLEIC ACIDS RESEARCH (2014)
Cardiovascular effects of statins, beyond lipid-lowering properties
Christos G. Mihos et al.
PHARMACOLOGICAL RESEARCH (2014)
UK consensus statement on safe clinical prescribing of bexarotene for patients with cutaneous T-cell lymphoma
J. J. Scarisbrick et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
THE CONCISE GUIDE TO PHARMACOLOGY 2013/14: CATALYTIC RECEPTORS
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
THE CONCISE GUIDE TO PHARMACOLOGY 2013/14: NUCLEAR HORMONE RECEPTORS
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
THE CONCISE GUIDE TO PHARMACOLOGY 2013/14: ENZYMES
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
THE CONCISE GUIDE TO PHARMACOLOGY 2013/14: G PROTEIN-COUPLED RECEPTORS
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Anti-atherosclerotic mechanisms of statin therapy
Andrea Babelova et al.
CURRENT OPINION IN PHARMACOLOGY (2013)
Effect of a Single High Loading Dose of Rosuvastatin on Percutaneous Coronary Intervention for Acute Coronary Syndromes
Zhengzhong Wang et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2013)
Inhibition of Rho and Rac Geranylgeranylation by Atorvastatin Is Critical for Preservation of Endothelial Junction Integrity
Hongbing Xiao et al.
PLOS ONE (2013)
Amplified Inhibition of Stellate Cell Activation Pathways by PPAR-γ, RAR and RXR Agonists
Efrat Sharvit et al.
PLOS ONE (2013)
Rosuvastatin reduced deep vein thrombosis in ApoE gene deleted mice with hyperlipidemia through non-lipid lowering effects
K. A. Patterson et al.
THROMBOSIS RESEARCH (2013)
Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Colin R. Dormuth et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Activation of mTOR/p70S6 kinase by ANG II inhibits insulin-stimulated endothelial nitric oxide synthase and vasodilation
Jeong-a Kim et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2012)
RANTES/CCL5-induced pro-angiogenic effects depend on CCR1, CCR5 and glycosaminoglycans
N. Suffee et al.
ANGIOGENESIS (2012)
Interplay between statins and PPARs in improving cardiovascular outcomes: a double-edged sword?
Pitchai Balakumar et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Retinoid X Receptor Agonists Impair Arterial Mononuclear Cell Recruitment through Peroxisome Proliferator-Activated Receptor-γ Activation
Maria-Jesus Sanz et al.
JOURNAL OF IMMUNOLOGY (2012)
Dissecting the Autocrine and Paracrine Roles of the CCR2-CCL2 Axis in Tumor Survival and Angiogenesis
Liat Izhak et al.
PLOS ONE (2012)
ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models
Paige E. Cramer et al.
SCIENCE (2012)
Interleukin-6: A Potential Target for Post-Thrombotic Syndrome
Brandon M. Wojcik et al.
ANNALS OF VASCULAR SURGERY (2011)
Statins exert differential effects on angiotensin II-induced atherosclerosis, but no benefit for abdominal aortic aneurysms
Jian-an Wang et al.
ATHEROSCLEROSIS (2011)
The PPAR-RXR Transcriptional Complex in the Vasculature Energy in the Balance
Jorge Plutzky
CIRCULATION RESEARCH (2011)
Angiotensin receptor blockers and angiogenesis: clinical and experimental evidence
Lauren M. Willis et al.
CLINICAL SCIENCE (2011)
Rosuvastatin prevents proteinuria and renal inflammation in nitric oxide-deficient rats
Jose Marcos Girardi et al.
CLINICS (2011)
PI3K/AKT/mTOR pathway in angiogenesis
Jayashree Karar et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2011)
Guidelines for reporting experiments involving animals: the ARRIVE guidelines
J. C. McGrath et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Statins suppress interleukin-6-induced monocyte chemo-attractant protein-1 by inhibiting Janus kinase/signal transducers and activators of transcription pathways in human vascular endothelial cells
Michihisa Jougasaki et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Animal research: Reporting in vivo experiments: The ARRIVE guidelines
Carol Kilkenny et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Rosuvastatin, Identified From a Zebrafish Chemical Genetic Screen for Antiangiogenic Compounds, Suppresses the Growth of Prostate Cancer
Chunyang Wang et al.
EUROPEAN UROLOGY (2010)
Thoracic aortic disease in tuberous sclerosis complex: molecular pathogenesis and potential therapies in Tsc2+/- mice
Jiumei Cao et al.
HUMAN MOLECULAR GENETICS (2010)
Simvastatin Inhibits Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in Apolipoprotein E-Knockout Mice Possible Role of ERK
Yali Zhang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Improved Pharmacokinetic and Bioavailability Support of Drug Discovery Using Serial Blood Sampling in Mice
Sean X. Peng et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Statin Adverse Effects A Review of the Literature and Evidence for a Mitochondrial Mechanism
Beatrice A. Golomb et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2008)
Rosuvastatin: efficacy, safety and clinical effectiveness
Handrean Soran et al.
EXPERT OPINION ON PHARMACOTHERAPY (2008)
Metabolic Switch and Hypertrophy of Cardiomyocytes following Treatment with Angiotensin II Are Prevented by AMP-activated Protein Kinase
Bettina Johanna Stuck et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Ras oncogenes: split personalities
Antoine E. Karnoub et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Vascular endothelial growth factor and its relationship to inflammatory mediators
Laura S. Angelo et al.
CLINICAL CANCER RESEARCH (2007)
The pro-inflammatory and chemotactic cytokine microenvironment of the abdominal aortic aneurysm wall: A protein array study
Rachel K. Middleton et al.
JOURNAL OF VASCULAR SURGERY (2007)
Activation of PPAR beta/delta induces endothelial cell proliferation and angiogenesis
Laura Piqueras et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
The RXR agonist bexarotene improves cholesterol homeostasis and inhibits atherosclerosis progression in a mouse model of mixed dyslipidemia
Fanny Lalloyer et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Abdominal aortic aneurysm - Pathogenesis and implications for management
Jonathan Golledge et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Abdominal aortic aneurysm rupture is associated with increased medial neovascularization and overexpression of proangiogenic cytokines
Edward Choke et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Simvastatin modulates chemokine and chemokine receptor expression by geranylgeranyl isoprenoid pathway in human endothelial cells and macrophages
Niels R. Veillard et al.
ATHEROSCLEROSIS (2006)
Angiotensin II-induced mononuclear leukocyte interactions with arteriolar and venular endothelium are mediated by the release of different CC chemokines
Teresa Mateo et al.
JOURNAL OF IMMUNOLOGY (2006)
The selective retinoid X receptor agonist bexarotene (LGD1069, Targretin) prevents and overcomes multidrug resistance in advanced breast carcinoma
WC Yen et al.
MOLECULAR CANCER THERAPEUTICS (2005)
ANG II activates effectors of mTOR via PI3-K signaling in human coronary smooth muscle cells
S Hafizi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
Rapamycin suppresses experimental aortic aneurysm growth
DM Lawrence et al.
JOURNAL OF VASCULAR SURGERY (2004)
Angiotensin II induces neutrophil accumulation in vivo through generation and release of CXC chemokines
YN Abu Nabah et al.
CIRCULATION (2004)
Retinoid X receptors: X-ploring their (patho)physiological functions
A Szanto et al.
CELL DEATH AND DIFFERENTIATION (2004)
Fenofibrate inhibits angiogenesis in vitro and in vivo
J Varet et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2003)
NF-κB, chemokine gene transcription and tumour growth
A Richmond
NATURE REVIEWS IMMUNOLOGY (2002)
3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA
HJ Park et al.
CIRCULATION RESEARCH (2002)
Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor- and inflammation-related pathways
R Tamarat et al.
LABORATORY INVESTIGATION (2002)
Abdominal aortic aneurysms: fresh insights from a novel animal model of the disease
MW Manning et al.
VASCULAR MEDICINE (2002)
分享论文
